XENETIC BIOSCIENCES
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2011-08-01
- Employees
- 4
- Market Cap
- $6.3M
- Website
- http://www.xeneticbio.com
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Xenetic Biosciences (NASDAQ:XBIO) released a Virtual Investor segment featuring Dr. Reid Bissonnette discussing preclinical data from the SITC 39th Annual Meeting, showing DNase I significantly improves anti-CTLA-4 immune checkpoint blockade efficacy in MSS/MMRp colorectal carcinoma models.
© Copyright 2024. All Rights Reserved by MedPath